Stock Monitor: Golden Minerals Post Earnings Reporting
LONDON, UK / ACCESSWIRE / March 16, 2018 / Active-Investors.com has just released a free earnings report on Cameco Corp. (NYSE: CCJ). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/'symbol=CCJ. The Company released its fourth quarter fiscal 2017 (Q4 FY17) and full fiscal year 2017 (FY17) earnings results on February 09, 2018. The Company reported a y-o-y growth in its adjusted diluted earnings per share (EPS). Register today and get access to over 1000 Free Research Reports by joining our site below:
www.active-investors.com/registration-sg
Active-Investors.com is currently working on the research report for Golden Minerals Company (NYSE AMER: AUMN), which also belongs to the Basic Materials sector as the Company Cameco. Do not miss out and become a member today for free to access this upcoming report at:
www.active-investors.com/registration-sg/'symbol=AUMN
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Cameco most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:
www.active-investors.com/registration-sg/'symbol=CCJ
Earnings Highlights and Summary
During Q4 FY17, Cameco reported total revenues of $809 million, which came in 9% lower than $887 million in Q4 FY16. Meanwhile, the Company's gross margin surged 51% to $237 million in Q4 FY17 from $157 million in the last year's same quarter.
The uranium producing Company reported a net loss attributable to equity holders of $62 million, or $0.16 loss per diluted share, in Q4 FY17 versus a net loss attributable to equity holders of $144 million, or $0.36 loss per diluted share, in the prior year's comparable quarter. Additionally, the Company's adjusted net earnings came in at $181 million, or $0.46 per diluted share, compared to $90 million, or $0.23 per diluted share, in Q4 FY16.
In FY17, Cameco's total revenues fell 11% to $2.16 billion from $2.43 billion in FY16. The Company's net loss attributable to equity holders was $205 million, or $0.52 loss per diluted share, in FY17 compared to a net loss attributable to equity holders of $62 million, or $0.16 loss per diluted share, in FY16. Moreover, the Company's adjusted earnings were $59 million, or $0.15 per diluted share, in FY17 compared to $143 million, or $0.36 per diluted share, in FY16.
Segment Results
The Saskatchewan, Canada-based Company's Uranium segment's production volume was 6.9 million lbs. during Q4 FY17 compared to 7.1 million lbs. in Q4 FY16. In the reported quarter, the Company's total uranium sales volume was 12.6 million lbs., up 8% from 11.7 million lbs. in Q4 FY16. The Company's average uranium released price was $50.04 per lbs., in Q4 FY17 versus $50.51 per lbs. in Q4 FY16. The Company's total uranium revenues increased to $631 million during Q4 FY17 from $589 million in Q4 FY16. Furthermore, the segment reported a gross profit of $216 million in Q4 FY17, which was 51% above $143 million in the previous year's corresponding quarter.
In Q4 FY17, Cameco's Fuel Services segment's production volume surged 32% to 2.5 million kilograms of elemental uranium (kgU) from 1.9 million kgU in Q4 FY16. The segment's sales volume increased to 4.6 kgU in Q4 FY17 from 4.0 kgU in the prior year's same quarter. In Q4 FY17, the segment's average realized price was $23.13 per kgU compared to $26.03 per kgU in Q4 FY16. The Fuel Services segment's revenues contributed $107 million to the Company's total revenues in Q4 FY17 compared to $104 million in Q4 FY16. In the reported quarter, the segment's gross profit was $22 million, which was 16% above $19 million in Q4 FY16.
Cameco's NUKEM segment's uranium sales was 4.0 million lbs. during Q4 FY17, up 29% from 3.1 million lbs. in Q4 FY16. The segment's average realized price declined to $30.81 per lbs. during Q4 FY17 from $46.63 per lbs. in Q4 FY16. The segment generated revenues of $124 million in Q4 FY17 versus $194 million in the prior year's comparable quarter. Furthermore, the segment posted a gross profit of $2 million in Q4 FY17 compared to a gross loss of $1 million in Q4 FY16.
Cash Flow and Balance Sheet
In the full fiscal year ended December 31, 2017, Cameco's net cash generated by operating activities rose to $596.05 million from $312.38 million in FY16. As on December 31, 2017, the Company's cash and cash equivalents balance stood at $591.62 million compared to $320.28 million as on December 31, 2016. Furthermore, the Company's long-term debt outstanding remained flat at $1.49 billion as on December 31, 2017.
Earnings Outlook
In its guidance for the full year FY18, Cameco anticipates consolidated revenues to be in the range of $1.80 billion to $1.93 billion. Uranium sale/delivery volume is forecasted to be between 32 million lbs. to 33 million lbs. Furthermore, full services sale/delivery volume is expected to be in the band of 11 million kgU to 12 million kgU.
Stock Performance Snapshot
March 15, 2018 - At Thursday's closing bell, Cameco's stock was marginally up 0.98%, ending the trading session at $9.23.
Volume traded for the day: 1.07 million shares.
Stock performance in the last month - up 2.33%
After yesterday's close, Cameco's market cap was at $3.65 billion.
The stock has a dividend yield of 3.47%.
The stock is part of the Basic Materials sector, categorized under the Industrial Metals & Minerals industry.
Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the 'Author') and is fact checked and reviewed by a third-party research service company (the 'Reviewer') represented by a credentialed financial analyst. For further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the 'Sponsor'), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active-Investors
